| Authors: |
Bal S; University of Alabama at Birmingham, Birmingham, Alabama, United States., Htut M; City of Hope, Duarte, California, United States., Nadeem O; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Anderson LD Jr; University of Texas Southwestern Medical Center, Dallas, Texas, United States., Gregory T; Colorado Blood Cancer Institute, Dever, Colorado, United States., Kocoglu M; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States., Rossi AC; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States., Martin TG; UCSF, San Francisco, California, United States., Egan DN; Swedish Cancer Institute, Seattle, Washington, United States., Costa LJ; University of Alabama at Birmingham, Vestavia Hills, Alabama, United States., Hu H; Bristol Myers Squibb, Princeton, New Jersey, United States., Chen J; Bristol Myers Squibb, Princeton, New Jersey, United States., Li S; Bristol Myers Squibb, Princeton, New Jersey, United States., Kelly LM; Bristol Myers Squibb, Princeton, New Jersey, United States., Sarkis N; Bristol Myers Squibb, Princeton, New Jersey, United States., Ziyad S; Bristol Myers Squibb, Princeton, New Jersey, United States., Jordahl KM; Bristol Myers Squibb, Princeton, New Jersey, United States., Kao WM; Bristol Myers Squibb, Brisbane, California, United States., Kaeding AJ; Bristol Myers Squibb, United States., Burgess MR; Bristol Myers Squibb, Princeton, New Jersey, United States., Berdeja JG; Greco-Hainsworth Tennessee Oncology Centers for Research, nashville, Tennessee, United States. |
